CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $67.69 ($16,923)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $66.62 ($1,332,400)
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 27,232 shares at an average $65.10 ($1,772,729)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 22,768 shares at an average $65.91 ($1,500,589)
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Regulation FD disclosure
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $67.79 ($16,948)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 2,799 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & CFO gave up 4,534 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $67.25 ($1,345,000)
Page 16 of 90 · 1,784 filings